-
-
Call more information
660-596-2224 -
Author: Hannah Lonsdale, MBChB ASA Monitor November 2023, Vol. 87, 22–23. Artificial intelligence (AI) is moving into every aspect of our lives: selecting the online advertisements that we see, recognizing our voices, showing us the best route home, and protecting us from credit card fraud. Machine learning (ML) refers to programs that use complex mathematical functions […]
Read MoreAbuse of which of the following illicit drugs is MOST likely to be associated with accelerated dental caries and tooth decay? (A) Lysergic acid (LSD) (B) Methamphetamine (C) Phencyclidine (PCP) A case of suspected meth mouth. This patient, who will remain anonymous, was treated at the University of Tennessee Health Science Center, College of Dentistry, […]
Read MoreASA Monitor November 2023, Vol. 87, 18. Vigil Neuroscience’s Alzheimer’s drug given FDA green light, with a partial clinical hold Vigil Neuroscience has been granted clearance from the FDA to launch an early-stage Alzheimer’s trial, but that approval comes with strings attached: a partial clinical hold. The FDA has approved Vigil’s investigational new drug application for […]
Read MoreAuthor: Ronald G. Pearl, MD, PhD, FASA, FCCM ASA Monitor November 2023, Vol. 87, 26–28. Critical care medicine is an ideal area for the use of artificial intelligence (AI) and machine learning (ML) (Crit Care 2022;26:75). Rounds in the ICU frequently include debates on diagnosis, treatment, prognosis, and the likelihood of patient deterioration. Critical care patients generate […]
Read MoreAuthors: Korina Katsaliaki, PhD et al ASA Monitor November 2023, Vol. 87, 20–21. Machine learning (ML) is a subfield of artificial intelligence (AI) specializing in the development of algorithms and models that enable computers to learn and make predictions or decisions without being explicitly programmed. It involves using statistical methods and computational models for extracting […]
Read More